-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q8iloBsTA0VJeBusmrhaPXmefZRgThLnLrwI2Czxcwhm3+Ii6FGrIvDIl4+UIvxz KIXMVqe2EWm3oxz+ReWLxw== 0000950157-96-000056.txt : 19960216 0000950157-96-000056.hdr.sgml : 19960216 ACCESSION NUMBER: 0000950157-96-000056 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960214 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SYNAPTIC PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000884939 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 222859704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-45417 FILM NUMBER: 96518897 BUSINESS ADDRESS: STREET 1: 215 COLLEGE RD CITY: PARAMUS STATE: NJ ZIP: 07652 BUSINESS PHONE: 2012611331 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CIBA GEIGY LTD CENTRAL INDEX KEY: 0000868073 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 60 WALL ST STREET 2: C/O MORGAN GUARANTY TRUST CO OF NEW YORK CITY: NEW YORK STATE: NY ZIP: 10260 BUSINESS PHONE: 2126483200 SC 13G 1 SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------------------ SCHEDULE 13G Under the Securities Exchange Act of 1934 Synaptic Pharmaceutical Corporation (Name of Issuer) Common Stock, Par Value $.01 Per Share (Title of Class of Securities) 87156 R 109 (CUSIP Number) Check the following box if a fee is being paid with this statement [x]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of less than five percent of such class.) (See Rule 13d-7.) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 pages CUSIP No. 87156 R 109 Page 2 of 5 pages 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Ciba-Geigy Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Switzerland 5 SOLE VOTING POWER 535,715 NUMBER OF SHARES 6 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY EACH 7 SOLE DISPOSITIVE POWER REPORTING 535,715 PERSON WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 535,715 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.5% 12 TYPE OF REPORTING PERSON CO Item 1(a). Name of Issuer: This Statement on Schedule 13G relates to the common stock, par value $.01 per share (the "Common Stock"), of Synaptic Pharmaceutical Corporation, a Delaware corporation ("Synaptic"). Item 2(a). Name of Person Filing: Ciba-Geigy Limited. Item 2(b). Address of Principal Business Office: 141 Klybeckstrasse, CH-4002 Basle, Switzerland Item 2(c). Citizenship: Ciba-Geigy Limited is a Swiss corporation. Item 2(d). Title of Class of Securities. Common stock, par value $.01 per share, of Synaptic. Item 2(e). CUSIP Number: 87156 R 109 Item 3. If this Statement is Filed Pursuant to Rules 13d-(b), or 13D-2(b), Check Whether the Person Filing is a: Not applicable. Item 4. Ownership. (a) Amount Beneficially Owned: 535,715 shares of Common Stock. (b) Percent of Class: 9.5% Page 3 of 5 (c) Number of Shares as to Which Ciba-Geigy Limited has: (i) sole power to vote or to direct the vote: 535,715 (ii) shared power to vote or to direct the vote: Zero (iii) sole power to dispose or to direct the disposition of: 535,715 (iv) shared power to dispose or to direct the disposition of: Zero Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. Not applicable. Page 4 of 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct. Date: February 13, 1996 CIBA-GEIGY LIMITED By: /s/ Dr. Herbert Gut ------------------------- Name: Dr. Herbert Gut Title: Senior Division Counsel /s/ Robin Walker ------------------------- Name: Robin Walker Title: Division Counsel Page 5 of 5 -----END PRIVACY-ENHANCED MESSAGE-----